Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Molina Healthcare Inc (NYSE: MOH) was $182.8 for the day, up 2.43% from the previous closing price of $178.46. In other words, the price has increased by $2.43 from its previous closing price. On the day, 1.81 million shares were traded. MOH stock price reached its highest trading level at $185.94 during the session, while it also had its lowest trading level at $179.8.
Ratios:
Our analysis of MOH’s different ratios will help us gain a deeper understanding of the company. In the meantime, Its Debt-to-Equity ratio is 0.92 whereas as Long-Term Debt/Eq ratio is at 0.92.
On October 16, 2025, TD Cowen Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $203.
On October 14, 2025, Goldman started tracking the stock assigning a Neutral rating and target price of $207.Goldman initiated its Neutral rating on October 14, 2025, with a $207 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 24 ’25 when Schapiro Richard M sold 357 shares for $143.02 per share. The transaction valued at 51,058 led to the insider holds 11,352 shares of the business.
Schapiro Richard M bought 357 shares of MOH for $50,536 on Nov 24 ’25. On Aug 06 ’25, another insider, ROMNEY RONNA, who serves as the Director of the company, sold 700 shares for $153.74 each. As a result, the insider received 107,618 and left with 17,131 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MOH now has a Market Capitalization of 9907760128 and an Enterprise Value of 4800920064. As of this moment, Molina’s Price-to-Earnings (P/E) ratio for their current fiscal year is 11.33, and their Forward P/E ratio for the next fiscal year is 13.33. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.21 while its Price-to-Book (P/B) ratio in mrq is 2.22. Its current Enterprise Value per Revenue stands at 0.112 whereas that against EBITDA is 3.295.
Stock Price History:
The Beta on a monthly basis for MOH is 0.49, which has changed by -0.3980707 over the last 52 weeks, in comparison to a change of 0.16067612 over the same period for the S&P500. Over the past 52 weeks, MOH has reached a high of $359.97, while it has fallen to a 52-week low of $133.40. The 50-Day Moving Average of the stock is 18.11%, while the 200-Day Moving Average is calculated to be -18.17%.
Shares Statistics:
MOH traded an average of 1.68M shares per day over the past three months and 1278410 shares per day over the past ten days. A total of 51.00M shares are outstanding, with a floating share count of 50.79M. Insiders hold about 1.20% of the company’s shares, while institutions hold 113.24% stake in the company. Shares short for MOH as of 1765756800 were 3621816 with a Short Ratio of 2.16, compared to 1763078400 on 3856991. Therefore, it implies a Short% of Shares Outstanding of 3621816 and a Short% of Float of 9.379999999999999.
Earnings Estimates
At present, 17.0 analysts are actively evaluating the performance of Molina Healthcare Inc (MOH) in the stock market.The consensus estimate for the next quarter is $3.75, with high estimates of $4.27 and low estimates of $3.24.
Analysts are recommending an EPS of between $14.26 and $13.34 for the fiscal current year, implying an average EPS of $13.93. EPS for the following year is $12.53, with 8.0 analysts recommending between $14.75 and $11.6.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 12 analysts. It ranges from a high estimate of $11.29B to a low estimate of $10.45B. As of. The current estimate, Molina Healthcare Inc’s year-ago sales were $10.5BFor the next quarter, 12 analysts are estimating revenue of $11.61B. There is a high estimate of $12.19B for the next quarter, whereas the lowest estimate is $11.16B.
A total of 15 analysts have provided revenue estimates for MOH’s current fiscal year. The highest revenue estimate was $45.51B, while the lowest revenue estimate was $44.48B, resulting in an average revenue estimate of $44.97B. In the same quarter a year ago, actual revenue was $40.65BBased on 15 analysts’ estimates, the company’s revenue will be $46.78B in the next fiscal year. The high estimate is $48.42B and the low estimate is $44.85B.
